ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Plans $0.13 Quarterly Dividend

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) announced a quarterly dividend on Tuesday, March 25th, NASDAQ Dividends reports. Shareholders of record on Wednesday, March 26th will be given a dividend of 0.1309 per share by the exchange traded fund on Tuesday, April 1st. This represents a $0.52 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date of this dividend is Wednesday, March 26th.

ProShares Ultra Nasdaq Biotechnology Price Performance

Shares of NASDAQ BIB traded down $1.66 during midday trading on Wednesday, reaching $50.63. 4,873 shares of the stock traded hands, compared to its average volume of 14,852. The company’s 50 day moving average is $54.24 and its 200 day moving average is $57.55. ProShares Ultra Nasdaq Biotechnology has a one year low of $47.20 and a one year high of $69.56. The stock has a market capitalization of $59.74 million, a PE ratio of 26.77 and a beta of 1.63.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.